Cetera Investment Advisers Crispr Therapeutics Ag Transaction History

Cetera Investment Advisers

$44.2 Billion
Q3 2024

A detailed history of Cetera Investment Advisers transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Cetera Investment Advisers holds 35,612 shares of CRSP stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,612

Previous 26,838 32.69%

Holding current value

$1.65 Million

Previous $1.45 Million 15.46%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$44.62 - $62.75 $391,495 - $550,568	8,774 Added 32.69%	35,612 $1.67 Million
Q2 2024 Aug 22, 2024	SELL	$51.17 - $68.18 $371,596 - $495,123	-7,262 Reduced 21.3%	26,838 $1.45 Million
Q1 2024 May 24, 2024	BUY	$60.67 - $89.12 $1.64 Million - $2.42 Million	27,109 Added 387.77%	34,100 $2.32 Million
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $48,900 - $71,830	806 Added 13.03%	6,991 $476,000
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $16,992 - $31,759	440 Added 7.66%	6,185 $387,000
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $1,724 - $2,242	38 Added 0.67%	5,745 $260,000
Q2 2023 Aug 09, 2023	SELL	$43.47 - $67.77 $109,500 - $170,712	-2,519 Reduced 30.62%	5,707 $320,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $15,334 - $20,988	-374 Reduced 4.35%	8,226 $372,000
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $76,694 - $128,516	1,957 Added 29.46%	8,600 $349,000
Q3 2022 Nov 10, 2022	SELL	$61.1 - $83.78 $86,823 - $119,051	-1,421 Reduced 17.62%	6,643 $434,000
Q2 2022 Aug 11, 2022	BUY	$43.23 - $73.83 $10,245 - $17,497	237 Added 3.03%	8,064 $490,000
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $45,902 - $68,384	863 Added 12.39%	7,827 $491,000
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $17,732 - $28,156	-253 Reduced 3.51%	6,964 $528,000
Q3 2021 Nov 16, 2021	BUY	$110.2 - $156.64 $89,151 - $126,721	809 Added 12.62%	7,217 $808,000
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $180,100 - $289,135	1,786 Added 38.64%	6,408 $1.04 Million
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $54,142 - $102,709	-489 Reduced 9.57%	4,622 $563,000
Q4 2020 Feb 17, 2021	BUY	$79.67 - $173.23 $407,193 - $885,378	5,111 New	5,111 $783,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Crispr Therapeutics Ag Transaction History